NIH runs the largest of the federal SBIR programs, and it is structured unlike the others. There is no single NIH funding line. Money sits inside institutes and centers — cancer, heart and lung, aging, mental health, allergy and infectious disease, biomedical imaging and bioengineering, and more — each with its own scientific priorities, its own program staff and its own appetite for what you are proposing. Picking the right institute is the first real decision, not an administrative detail.
Omnibus versus targeted opportunities
Most NIH SBIR applications come in through the omnibus solicitation, a broad invitation under which participating institutes list the research topics they are interested in. Alongside it, institutes publish targeted funding opportunities for specific problems, sometimes with set-aside funds and their own review arrangements. A targeted opportunity that matches your work is usually the better bet, because someone has already decided this problem deserves money. Read the institute's stated interests before you decide which route to take.
Study-section peer review
NIH applications are reviewed by study sections — standing panels of outside scientists who score applications on criteria such as significance, investigators, innovation, approach and environment. This is academic peer review adapted for small business, and it shows: the reviewers are usually researchers, and a proposal that reads like a product brochure without experimental design fares badly. Scoring, discussion order and the way percentile ranks work are worth understanding before you submit, and the general shape is covered in how review panels score proposals.
Because review and funding are separate steps at NIH, a good score does not guarantee an award. The institute decides what to fund from the scored pool according to its own priorities and budget. Resubmission after a first decline is normal and often successful; the summary statement tells you what the panel actually objected to. Expect the whole cycle to be slow — see how long SBIR decisions take.
Talk to a program officer before you write
At NIH more than anywhere, contacting the program officer at the relevant institute before submission is standard practice, not an imposition. They will tell you whether your idea fits their portfolio, which opportunity to apply under, and sometimes that another institute is the better home. That conversation is the single highest-return hour in the process, and how to approach it is worth reading first.
Who NIH suits
NIH fits companies whose product improves health: diagnostics, therapeutics, medical devices, digital health, research tools and lab instrumentation. It suits teams that can write and defend a research plan, and that can be honest about regulatory strategy — a device proposal is stronger when it names its likely FDA pathway rather than waving at it. Device founders should also read NIH funding paths for medical device startups. Award sizes, budget ceilings above the standard guidelines and clinical-trial designations all vary by institute and change over time; confirm each in the current notice.
Projects House does the device engineering, prototyping and verification testing that an NIH proposal has to promise and a Phase II has to deliver. Start a conversation through the contact form.